Current Screening Might Miss Prostate Cancer in Transgender Women

Source: U.S. News and World ReportCurrent screening standards could miss early-stage prostate cancer in transgender women, warns a study published June 26 in the Journal of the American Medical Association. Prostate cancer blood tests look for high levels of prostate-specific antigen (PSA), but the estrogen many transgender women take as part of their gender-affirming care sharply lowers PSA levels, which means that the threshold for detecting cancer may be too high for trans...